Rationale and Study Design of Phase-3 Clinical Development Program for Samelisant (SUVN-G3031) in the Treatment of Excessive Daytime Sleepiness in Patients with Narcolepsy

Sleep Medicine 2026

View at publisher

Authors: V.K. Goyal, A. Shinde, Ramkumar Subramanian, Pradeep Jayarajan, Ramakrishna V. S. Nirogi

DOI: 10.1016/j.sleep.2025.107608

Cited by: 0

Fields of Study & Subjects

Sleep and Wakefulness Research Sleep and related disorders Sleep and Work-Related Fatigue